Royal Bank of Canada
ANVS icon

Royal Bank of Canada’s Annovis Bio ANVS Stock Holding History

Royal Bank of Canada’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-314
Closed -$1K – 7068
2025
Q4 		$1K Buy
+314
New +$944 ﹤0.01% 6957
2025
Q3 		– Sell
-1,564
Closed -$3K – 7099
2025
Q2 		$3K Buy
+1,564
New +$3.09K ﹤0.01% 6720
2024
Q3 		– Sell
-72
Closed – – 6811
2024
Q2 		$0 Buy
72
+68
+1,700% +$551 ﹤0.01% 7004
2024
Q1 		$0 Sell
4
-36
-90% -$393 ﹤0.01% 6973
2023
Q4 		$1K Hold
40
– – ﹤0.01% 6883
2023
Q3 		$0 Sell
40
-90
-69% -$1.11K ﹤0.01% 7044
2023
Q2 		$2K Buy
+130
New +$1.84K ﹤0.01% 6839
2022
Q4 		– Sell
-4
Closed – – 7185
2022
Q3 		$0 Buy
+4
New +$53 ﹤0.01% 7410
2022
Q1 		– Sell
-3
Closed – – 7711
2021
Q4 		$0 Buy
+3
New +$77 ﹤0.01% 7627

Other funds holding ANVS

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Royal Bank of Canada's ANVS Position: Q1 2026 in Review

Royal Bank of Canada sold out of Annovis Bio (ANVS) in Q1 2026, closing a stake of 314 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in ANVS in Q4 2021 and held it in 9 quarters. The position peaked at $3K in Q2 2025. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.

  • Royal Bank of Canada reported no remaining Annovis Bio position as of Q1 2026 after selling out during the quarter.
  • Royal Bank of Canada sold 314 Annovis Bio shares in Q1 2026, an estimated $1K.
  • Royal Bank of Canada first reported a position in Annovis Bio in Q4 2021 and held it in 9 quarters.
  • Royal Bank of Canada's Annovis Bio position peaked at $3K in Q2 2025.
  • 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.